|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.44 EUR | +0.62% |
|
+0.62% | +2.98% |
| 22/04 | Michael Hamelryck to replace Stefaan Vandamme as CFO of Colruyt | RE |
| 02/03 | Colruyt completes sale of French integrated retail stores | RE |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Grocery Stores | ||||||||||
Food | - | - | - | - | 1.04TCr | |||||
CAPEX | - | - | - | - | -4.74Cr | |||||
D&A | - | - | - | - | 7.1Cr | |||||
Operating Income | - | - | - | - | 45Cr | |||||
Retail | 837.36Cr | 823.33Cr | 882.22Cr | 965.27Cr | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | -31Cr | -37Cr | -34Cr | -31Cr | - | |||||
EBITDA | 69Cr | 63Cr | 57Cr | 78Cr | - | |||||
D&A | 25Cr | 27Cr | 29Cr | 30Cr | - | |||||
Operating Income | 44Cr | 35Cr | 24Cr | 43Cr | - | |||||
Drug Stores and Pharmacies | ||||||||||
Health & Well-being and Non-food | - | - | - | - | 50Cr | |||||
CAPEX | - | - | - | - | -2.81Cr | |||||
D&A | - | - | - | - | 3.66Cr | |||||
Operating Income | - | - | - | - | 25L | |||||
Printing Services | ||||||||||
Group Activities, Real Estate and Energy | - | - | - | - | 2.88Cr | |||||
CAPEX | - | - | - | - | -40Cr | |||||
D&A | - | - | - | - | 30Cr | |||||
Operating Income | - | - | - | - | -83L | |||||
Other Activities | 56Cr | 83Cr | 93Cr | 17Cr | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | -2Cr | -2.08Cr | -1.8Cr | -37L | - | |||||
EBITDA | 6.3Cr | 2.6Cr | 3.9Cr | 90L | - | |||||
D&A | 1.2Cr | 1.22Cr | 1.16Cr | 41L | - | |||||
Operating Income | 5.09Cr | 1.41Cr | 2.69Cr | 60L | - | |||||
Corporate | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBITDA | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
CAPEX | -12Cr | -7.21Cr | -8.63Cr | -11Cr | - | |||||
EBITDA | 1.7Cr | -1.1Cr | 1.7Cr | - | - | |||||
D&A | 4.58Cr | 5.18Cr | 3.79Cr | 5.54Cr | - | |||||
Operating Income | -2.92Cr | -4.17Cr | -5.66Cr | -2.6Cr | - | |||||
Eliminations | -8.75Cr | -9.91Cr | -100.04Cr | -38Cr | -89L | |||||
CAPEX | - | - | - | 13L | - | |||||
EBITDA | - | - | - | 3Cr | - | |||||
D&A | - | - | - | -11L | - | |||||
Operating Income | - | - | - | 1.73Cr | - | |||||
Food Distribution | ||||||||||
Wholesale and Foodservice | 108.81Cr | 108.22Cr | 118.29Cr | 140.84Cr | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | -1.52Cr | -2.55Cr | -2.29Cr | -1.65Cr | - | |||||
EBITDA | 7.7Cr | 7.2Cr | 6.1Cr | 7.5Cr | - | |||||
D&A | 1.99Cr | 2.07Cr | 2.31Cr | 2.99Cr | - | |||||
Operating Income | 5.68Cr | 5.11Cr | 3.79Cr | 4.47Cr | - |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Belgium | 918.01Cr | 926.61Cr | 907.61Cr | 980.2Cr | 986.18Cr | |||||
Total Assets | - | - | - | 300.4Cr | 319.94Cr | |||||
CAPEX | -43Cr | -44Cr | -39Cr | - | - | |||||
France | 69Cr | 71Cr | 78Cr | 96Cr | 101.44Cr | |||||
Total Assets | - | - | - | 33Cr | 33Cr | |||||
CAPEX | -3.73Cr | -4.45Cr | -6.72Cr | - | - | |||||
Other | 6.28Cr | 7.12Cr | 7.68Cr | 8.51Cr | 8.71Cr | |||||
Total Assets | - | - | - | 5.9Cr | 6.29Cr | |||||
CAPEX | -4L | -49L | -45L | - | - |
- Stock Market
- Equities
- COLR Stock
- Financials Colruyt Group NV
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition